Dynamic thermal treatments are related to crystallization processes of edible fats.Complex polymorphic behavior of TAGs was monitored by varying kinetic conditions.Polymorphic transformation pathways were discussed in terms of molecular structures.Functional polymorphs may be formed by tailoring most efficient ...
The rate of absorption can also depend on the type of diet consumed, particularly if the diet has a high concentration of fats. These factors, as well as others known to those of skill in the art that can affect the absorption of proton pump inhibitors, can consequently influence the ...
increase; 95% CI: 0.62, 0.88) and alpha-tocopherol equivalents (relative risk: 0.56 per 5 mg/d increase; 95% CI: 0.32, 0.98) were associated with a reduced incidence of Alzheimer disease in separate multiple-adjusted models that included intakes of saturated and trans fats and docosahexaenoic...
The present invention pertains generally to the field of therapeutic compounds, and more specifically to crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl
Oral dosage form containing a therapeutically effective amount of a drug susceptible to abuse and an effective amount of an embolizing agent which causes the production of a solid or semi-solid embolus or blockage after tampering. Skip to: Description · Claims · Patent History · Patent History...
Other vegetable-, animal-, mineral-, and synthetic-derived fats and waxes also are suitable. [0032] The lipid coating can be a mixture of different lipids. For example, in addition to the preferred hydrogenated vegetable oils, other lipids which can be incorporated in the lipid coating ...
Orlistat prevents the absorption of fats from the human diet, thereby reducing caloric intake. Orlistat works by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable ...
Approximate solubility was measured by preparation of saturated solutions in various solvents and gravimetric determination of dissolved substance after solvent removal. The results are given in Table 3. TABLE 3 Approximate solubility of the crystalline Form A of compound of formula IV Solvent Solubility...
The invention provides a biphasic multicomponent pharmaceutical composition consisting of an oil phase and a water phase, comprising one or more lipophilic or oil carrier, one or more hydrophilic or a
Low levels of docosahexaenoic acid (DHA) in the brain have been related to neurological disorders, like Alzheimer’s disease (AD). After ingestion, dietary DHA must cross the blood–brain barrier, where it is absorbed as lysophosphatidylcholine (LPC), du